How DARZALEX® is given
DARZALEX® is an intravenous (IV) infusion, given through a needle placed in a vein by a healthcare professional. It may be given alone or with other medicines to treat your multiple myeloma.
Your healthcare professional will determine your dose of DARZALEX® based on your weight and the time between doses based on which DARZALEX® regimen you receive.
If you miss an appointment, be sure call your doctor as soon as possible to reschedule.
DARZALEX® infusion schedules
- I am newly diagnosed and cannot receive a stem cell transplant that uses my own stem cells (autologous stem cell transplant)
- I have received at least one prior medicine to treat my multiple myeloma
- I have received at least two prior medicines to treat my multiple myeloma, including Revlimid® (lenalidomide) and a proteasome inhibitor
- I have received at least three prior medicines to treat my multiple myeloma, including a proteasome inhibitor and an immunomodulatory agent, or if a proteasome inhibitor and an immunomodulatory agent did not work for me
Your healthcare provider will develop a treatment plan that is suited to your needs. If you have questions about your regimen, follow up with your doctor.
Create a calendar with your treatment schedule
Based on your medical history, your doctor may discuss treatment with DARZALEX® in combination with other medicines or as a monotherapy.
Select the date on which you expect to receive your first DARZALEX® treatment. Once a date is selected, recommended subsequent treatment dates will automatically populate the calendar.*
Tap a date to begin.
*Please note that dates provided are recommendations for infusion visits only. Your doctor is likely to schedule additional follow-up/care visits and may alter the dates for your infusions.
Want a PDF of this treatment schedule?